ISS
REGN icon

Intesa Sanpaolo SpA.’s Regeneron Pharmaceuticals REGN Stock Holding History

Intesa Sanpaolo SpA.’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
670
+50
+8% +$34K 0.01% 156
2026
Q1 		$473K Sell
620
-470
-43% -$360K 0.03% 135
2025
Q4 		$848K Buy
+1,090
New +$740K 0.05% 123

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Intesa Sanpaolo SpA.'s REGN Position: Q2 2026 in Review

Intesa Sanpaolo SpA. increased its Regeneron Pharmaceuticals (REGN) stake by 8.1% in Q2 2026, buying an estimated $34K and bringing the position to 670 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #156.

Intesa Sanpaolo SpA. first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $848K in Q4 2025. 1,330 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Intesa Sanpaolo SpA. held 670 shares of Regeneron Pharmaceuticals worth $418K as of Q2 2026.
  • Intesa Sanpaolo SpA. bought 50 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $34K.
  • Regeneron Pharmaceuticals made up 0.01% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #156 holding.
  • Intesa Sanpaolo SpA. first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Intesa Sanpaolo SpA.'s Regeneron Pharmaceuticals position peaked at $848K in Q4 2025.
  • 1,330 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.